首页> 外文会议>International Meeting on Computational Intelligence Methods for Bioinformatics and Biostatistics >Multiple Sclerosis Disease: A Computational Approach for Investigating Its Drug Interactions
【24h】

Multiple Sclerosis Disease: A Computational Approach for Investigating Its Drug Interactions

机译:多发性硬化症疾病:调查其药物相互作用的计算方法

获取原文

摘要

Multiple Sclerosis (MS) is a chronic and potentially highly disabling disease that can cause permanent damage and deterioration of the central nervous system. In Europe it is the leading cause of nontraumatic disabilities in young adults, since more than 700,000 EU people suffer from MS. Although recent studies on MS pathophysiology have been performed, providing interesting results, MS remains a challenging disease. In this context, thanks to recent advances in software and hardware technologies, computational models and computer simulations are becoming appealing research tools to support scientists in the study of such disease. Motivated by this consideration, we propose in this paper a new model to study the evolution of MS in silico, and the effects of the administration of the daclizumab drug, taking into account also spatiality and temporality of the involved phenomena. Moreover, we show how the intrinsic symmetries of the model we have developed can be exploited to drastically reduce the complexity of its analysis.
机译:多发性硬化症(MS)是一种慢性且潜在的高度致残疾病,可导致中枢神经系统的永久性损伤和恶化。在欧洲,它是年轻人非创伤性疾病的主要原因,因为超过70万欧盟人民患有MS。尽管最近对MS病理生理学进行了研究,但提供了有趣的结果,MS仍然是一个挑战性的疾病。在这种情况下,由于软件和硬件技术的最近进步,计算模型和计算机模拟正在成为支持这种疾病研究中科学家的吸引力的研究工具。通过这一考虑,我们提出了研究硅中MS的演变的新模型,以及施用Daclizumab药物的影响,考虑到涉及现象的空间性和暂时性。此外,我们展示了我们开发的模型的内在对称性如何利用,以大大降低其分析的复杂性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号